Abstract
Purpose
Fetuin A is associated with insulin resistance and type 2 diabetes mellitus (DM). We aimed to investigate circulating fetuin A concentrations in gestational diabetes mellitus (GDM).
Methods
Serum fetuin A levels were studied in 26 pregnant women with GDM and 24 healthy pregnant women between 24th and 28th gestational weeks. Fetuin A levels were also evaluated in 18 of women with GDM at postpartum.
Results
Fetuin A concentrations were significantly increased in women with GDM compared to healthy pregnant women (35.0 ± 3.2 vs. 32.0 ± 4.4 ng/ml; p = 0.01). Also, fetuin A levels in women with GDM significantly decreased at postpartum period (35.0 ± 3.2 vs. 31.7 ± 3.9 ng/ml; p = 0.001). In whole pregnant women, there were positive correlations between fetuin A and HbA1c (r = 0.418, p = 0.002), total cholesterol (r = 0.332, p = 0.018) and triglycerides (r = 0.306, p = 0.031). Multivariate regression analysis demonstrated that HbA1c was the important predictor of circulating fetuin A level (beta = 0.375, p = 0.01).
Conclusion
In conclusion, our results indicate that serum fetuin A concentrations are increased in women with GDM and decreased after delivery. Therefore, fetuin A might have a role in the development of insulin resistance and the metabolic changes in GDM.
Similar content being viewed by others
References
Arnaud P, Miribel L, Emerson DL (1988) Alpha 2-HS glycoprotein. Methods Enzymol 163:431–441
Mori K, Emoto M, Inaba M (2011) Fetuin-A: a multifunctional protein. Recent Pat Endocr Metab Immune Drug Discov 5(2):124–146
Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Krober SM, Machicao F, Fritsche A, Haring HU (2006) Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 29(4):853–857
Enli Y, Fenkci SM, Fenkci V, Oztekin O (2013) Serum Fetuin-A levels, insulin resistance and oxidative stress in women with polycystic ovary syndrome. Gynecol Endocrinol 29(12):1036–1039. doi:10.3109/09513590.2013.829442
Ou HY, Yang YC, Wu HT, Wu JS, Lu FH, Chang CJ (2011) Serum fetuin-A concentrations are elevated in subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes. Clin Endocrinol 75(4):450–455. doi:10.1111/j.1365-2265.2011.04070.x
Singh M, Sharma PK, Garg VK, Mondal SC, Singh AK, Kumar N (2012) Role of fetuin-A in atherosclerosis associated with diabetic patients. J Pharm Pharmacol 64(12):1703–1708. doi:10.1111/j.2042-7158.2012.01561.x
Song A, Xu M, Bi Y, Xu Y, Huang Y, Li M, Wang T, Wu Y, Liu Y, Li X, Chen Y, Wang W, Ning G (2011) Serum fetuin-A associates with type 2 diabetes and insulin resistance in Chinese adults. PLoS One 6(4):e19228. doi:10.1371/journal.pone.0019228
Sun Q, Cornelis MC, Manson JE, Hu FB (2013) Plasma levels of fetuin-A and hepatic enzymes and risk of type 2 diabetes in women in the US. Diabetes 62(1):49–55. doi:10.2337/db12-0372
Mathews ST, Chellam N, Srinivas PR, Cintron VJ, Leon MA, Goustin AS, Grunberger G (2000) Alpha2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor. Mol Cell Endocrinol 164(1–2):87–98
Catalano PM (2014) Trying to understand gestational diabetes. Diabet Med 31(3):273–281. doi:10.1111/dme.12381
Huopio H, Cederberg H, Vangipurapu J, Hakkarainen H, Paakkonen M, Kuulasmaa T, Heinonen S, Laakso M (2013) Association of risk variants for type 2 diabetes and hyperglycemia with gestational diabetes. Eur J Endocrinol 169(3):291–297. doi:10.1530/EJE-13-0286
Kim C, Newton KM, Knopp RH (2002) Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25(10):1862–1868
Barbour LA, McCurdy CE, Hernandez TL, Friedman JE (2011) Chronically increased S6K1 is associated with impaired IRS1 signaling in skeletal muscle of GDM women with impaired glucose tolerance postpartum. J Clin Endocrinol Meta 96(5):1431–1441. doi:10.1210/jc.2010-2116
Kalabay L, Cseh K, Pajor A, Baranyi E, Csakany GM, Melczer Z, Speer G, Kovacs M, Siller G, Karadi I, Winkler G (2002) Correlation of maternal serum fetuin/alpha2-HS-glycoprotein concentration with maternal insulin resistance and anthropometric parameters of neonates in normal pregnancy and gestational diabetes. Eur J Endocrinol 147(2):243–248
Farhan S, Handisurya A, Todoric J, Tura A, Pacini G, Wagner O, Klein K, Jarai R, Huber K, Kautzky-Willer A (2012) Fetuin-A characteristics during and after pregnancy: result from a case control pilot study. Int J Endocrinol 2012:896736. doi:10.1155/2012/896736
Coustan DR, Carpenter MW (1998) The diagnosis of gestational diabetes. Diabetes Care 21(Suppl 2):B5–B8
Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18(6):499–502
Denecke B, Graber S, Schafer C, Heiss A, Woltje M, Jahnen-Dechent W (2003) Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A. Biochem J 376(Pt 1):135–145. doi:10.1042/BJ20030676
Olivier E, Soury E, Ruminy P, Husson A, Parmentier F, Daveau M, Salier JP (2000) Fetuin-B, a second member of the fetuin family in mammals. Biochem J 350(Pt 2):589–597
Briana DD, Boutsikou M, Gourgiotis D, Boutsikou T, Baka S, Marmarinos A, Hassiakos D, Malamitsi-Puchner A (2008) Serum fetuin-A/alpha2-HS-glycoprotein in human pregnancies with normal and restricted fetal growth. J Matern Fetal Neonatal Med 21(11):826–830. doi:10.1080/14767050802326255
Gunduz FO, Yildirmak ST, Temizel M, Faki Y, Cakmak M, Durmuscan M, Sezgin F (2011) Serum visfatin and fetuin-a levels and glycemic control in patients with obese type 2 diabetes mellitus. Diabetes Metab J 35(5):523–528. doi:10.4093/dmj.2011.35.5.523
Erdmann J, Salmhofer H, Knauss A, Mayr M, Wagenpfeil S, Sypchenko O, Luppa P, Schusdziarra V (2012) Relationship of fetuin-A levels to weight-dependent insulin resistance and type 2 diabetes mellitus. Regul Pept 178(1–3):6–10. doi:10.1016/j.regpep.2012.02.004
Liu Y, Xu M, Xu Y, Li M, Wang T, Chen Y, Bi Y (2012) Positive correlation between chronic hyperglycemia and serum fetuin-A levels in middle-aged and elderly Chinese. J Diabetes 4(4):351–358. doi:10.1111/1753-0407.12000
Ozyazgan S, Karaoglu K, Kurt A, Altinok A, Konukoglu D, Osar Siva Z, Andican G (2013) Effects of omega-3 polyunsaturated fatty acid supplementation on serum fetuin-A levels in type 2 diabetic patients. Minerva Med 104(3):287–293
Jung CH, Kim BY, Kim CH, Kang SK, Jung SH, Mok JO (2013) Associations of serum fetuin-A levels with insulin resistance and vascular complications in patients with type 2 diabetes. Diab Vasc Dis Res 10(5):459–467. doi:10.1177/1479164113490766
Stefan N, Haring HU (2013) Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans. Nat Med 19(4):394–395. doi:10.1038/nm.3116
Pal D, Dasgupta S, Kundu R, Maitra S, Das G, Mukhopadhyay S, Ray S, Majumdar SS, Bhattacharya S (2012) Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med 18(8):1279–1285. doi:10.1038/nm.2851
Acknowledgments
We gratefully thank Elif Ayvali for helping in laboratory analysis.
Conflict of interest
There is no conflict of interest to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Iyidir, O.T., Degertekin, C.K., Yilmaz, B.A. et al. Serum levels of fetuin A are increased in women with gestational diabetes mellitus. Arch Gynecol Obstet 291, 933–937 (2015). https://doi.org/10.1007/s00404-014-3490-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-014-3490-3